Therapeutic Approach

Archive: October, 2019

Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives

Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives LOS ANGELES (October 7, 2019) – Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, announced that it has engaged A.G.P./Alliance Global Partners as financial advisor to explore and evaluate strategic […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD